NEW GUIDANCE ON THERAPEUTIC DRUG MONITORING; POTENTIAL CLINICAL AND COST IMPLICATIONS

被引：0
|
作者：
Felwick, Richard [1 ]
Johnson, Heather [1 ]
Dewhurst, Hannah [1 ]
Cadogan, Ernest [1 ]
Hovell, Chris [1 ]
Weaver, Sean [1 ]
McLaughlin, Simon [1 ]
机构：
[1] Royal Bournemouth Hosp, Bournemouth, Dorset, England
来源：
GUT | 2018年 / 67卷
关键词：
D O I：
10.1136/gutjnl-2018-BSGAbstracts.150
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PWE-018
引用
收藏
页码：A76 / A77
页数：2
相关论文
共 50 条
  • [1] New guidance on therapeutic drug monitoring; potential clinical and cost implication
    Felwick, R.
    Johnson, H.
    Dewhurst, H.
    Cadogan, E.
    Hovell, C.
    Weaver, S.
    McLaughlin, S.
    JOURNAL OF CROHNS & COLITIS, 2018, 12 : S371 - S371
  • [2] Therapeutic drug monitoring of antidepressants - Cost implications and relevance to clinical practice
    Burke, MJ
    Preskorn, SH
    CLINICAL PHARMACOKINETICS, 1999, 37 (02) : 147 - 165
  • [3] Therapeutic drug monitoring of amisulpride:: clinical implications
    Müller, MJ
    Sachse, J
    Vernaleken, I
    Gründer, G
    Härtter, S
    Hiemke, C
    PSYCHOPHARMAKOTHERAPIE, 2003, 10 (01): : 23 - 27
  • [4] Therapeutic drug monitoring of amisulpride:: Clinical implications
    Müller, MJ
    Sachse, J
    Vernaleken, I
    Gründer, G
    Härtter, S
    Hiemke, C
    PHARMACOPSYCHIATRY, 2002, 35 (04) : VI - VI
  • [5] Therapeutic Drug Monitoring of AntidepressantsCost Implications and Relevance to Clinical Practice
    Michael J. Burke
    Sheldon H. Preskorn
    Clinical Pharmacokinetics, 1999, 37 : 147 - 165
  • [6] Therapeutic Drug Monitoring: The Need for Practical Guidance
    Alffenaar, Jan-Willem C.
    Heysell, Scott K.
    Mpagama, Stellah G.
    CLINICAL INFECTIOUS DISEASES, 2019, 68 (06) : 1065 - 1066
  • [7] Therapeutic Drug Monitoring of Atypical AntipsychoticsIs It of Potential Clinical Value?
    Paul J. Perry
    CNS Drugs, 2000, 13 : 167 - 171
  • [8] Therapeutic drug monitoring of atypical antipsychotics - Is it of potential clinical value?
    Perry, PJ
    CNS DRUGS, 2000, 13 (03) : 167 - 171
  • [9] Clinical Pharmacokinetics of Tyrosine Kinase Inhibitors: Implications for Therapeutic Drug Monitoring
    Josephs, Debra H.
    Fisher, Danielle S.
    Spicer, James
    Flanagan, Robert J.
    THERAPEUTIC DRUG MONITORING, 2013, 35 (05) : 562 - 587
  • [10] POTENTIAL COST-EFFECTIVENESS OF THERAPEUTIC DRUG MONITORING IN PATIENTS WITH RESISTANT HYPERTENSION
    Chung, O.
    Vongpatanasin, W.
    Haverkamp, W.
    Dorenkamp, M.
    VALUE IN HEALTH, 2014, 17 (07) : A486 - A486
12345